Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Senior Director, Quality Assurance GCP provides strategic leadership and quality oversight for the company’s clinical projects and is accountable for the GCP Quality Assurance function. This role leads the development, planning, and execution of audits and owns inspection readiness and regulatory inspection outcomes to ensure compliance with regulatory standards and company policies and procedures. The ideal candidate is comfortable working independently while leading and developing the QA GCP team and managing complex interactions with internal and external stakeholders, including CROs and regulatory authorities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level